Continuing Royalties Clause Samples

Continuing Royalties. Due on the first of June 2017, and on the corresponding day of each year thereafter until the patent expires, Licensee shall pay to Licensor a sum equal to ten percent (10%) of any sub-license fees earned on the Licensed Property in the prior twelve months. In the event that Licensee initiates a lawsuit to enforce the Licensed Property against any potential infringer, any settlement or judgment resulting from said lawsuit shall be considered a sub-license fee to which Licensor is entitled (10%) ten percent. 2.2.1. A sub-licensee shall be any entity that contracts with and pays the Licensee for the explicit right to use or be exempt from suits for using the Licensed Property. This does not include an entity contracting with the Licensee for products or services that may embody the Licensed Property.
Continuing Royalties. (a) BUYER shall pay SELLER Continuing Royalties of Three Percent (3%) of gross sales of alcohol or cocaine detoxification Process (defined below) BUYER (or any licensee) performs using the Intellectual Property for so long as BUYER (or any licensee) uses the Intellectual Property. (b) Continuing Royalties shall be paid by BUYER to SELLER on all collected funds for each Payment Period no later than the Payment Date. (c) BUYER shall tender payments of the Continuing Royalties due on each Payment Date by wire transfer to such account or accounts as SELLER may designate in advance. (d) BUYER shall pay the Continuing Royalties in US Dollars. (e) BUYER's obligation to pay Continuing Royalties to SELLER shall terminate after the public disclosure (other than as a result of a breach by BUYER of Section 8.1) of all Intellectual Property knowhow and the expiration of the last to expire of all Intellectual Property patents that are enforceable within the Territory. (f) In the event that Buyer shall make any improvements to the Intellectual Property, BUYER shall continue to be obligated to pay Continuing Royalties of Three Percent (3%) to SELLER of gross sales of alcohol or cocaine detoxification Processes BUYER (or any licensee) performs using the Intellectual Property and any improvements thereto.
Continuing Royalties. 4.1 On or before the 10th day of each month, you will, without notice from Franchisor, pay Franchisor a Royalty Fee in the amount of 8% of Gross Revenues of the preceding month or partial month. Gross Revenues is defined in Section 6. 4.2 Each Royalty Fee payment will be accompanied by a statement of the previous month's Gross Revenues on a form approved by Franchisor. 4.3 If you are unable to operate from the Outlet due to damage or loss to the Outlet caused or created by a casualty, act of God, condemnation, or other condition over which you have no control, then the Royalty Fee will be waived for a period no greater than 1 year commencing with the month in which the damage or loss occurs.
Continuing Royalties. For payment of the initial license fee above, Phoenix may keep the first XXX in Net Revenue (as defined below) from the sale, license and maintenance of the Products. In addition to the initial license fee, after the first XXXX in NetRevenue, Phoenix shall pay to Dyad a percentage of its Net Revenues as follows: (i) XX of the Net Revenue received by Phoenix from the XXXXXX of the Products including, without limitation, XXXXXXXXXXXXX; (ii) XXX of its Net Revenue from XXXXXXXX of the Products; and (iii) Phoenix and Dyad shall XXXXXXXXX based on XXXXXXXXXX. It is anticipated that Dyad will assist with initial implementations and that Phoenix will eventually handle implementations on its own. Amounts due Dyad hereunder shall be paid to Dyad by the tenth business day following the receipt of such revenue by Phoenix, and shall be accompanied by the name of the End User, their address, and the number of locations where each End User is using the Products.
Continuing Royalties. Following the expiration of the Royalty Term in respect of a Lumacan Product in a country in the Salix Territory, Salix shall, as consideration for its continued right to use the Licensed Trademarks and Licensed Technical Information for such Lumacan Product, pay royalties (“Continuing Royalties”) to Photocure in respect of Net Sales by Salix and its Affiliates and Sublicensees at the rate of [*] percent ([*]%) for as long as Salix or its Affiliates or Sublicensees Commercialize such Lumacan Product in such country. Prior to such expiration of the Royalty Term, the Parties acknowledge and agree that the Continuing Royalties for which provision is made in this Section 4.5(c) are included in the Royalties payable under Section 4.5(a).
Continuing Royalties. Following said payment of $150,000.00, FSTI will pay to AAC a continuing royalty of three percent (3%) of all net sales (pre-tax) of UNICORN Products thereafter. For purposes of this Agreement, the term "net sales" shall mean all revenues received by FSTI from all sources, less any sales taxes actually paid by FSTI (and separately itemized on any billing statements or contracts), in connection with sales, contracts, leases, assignments, licenses, etc., of UNICORN Products over and above the initial UNICORN sales of One Million Dollars ($1,000,000.00) described in Section 2(b) above.
Continuing Royalties. (a) Buyer shall pay Seller royalties (the “Continuing Royalties”) on the Component Cost of all Products that incorporate or use the Intellectual Property. (b) Buyer shall have no further obligation to pay Continuing Royalties to Buyer on Products that are sold after the date on which the last Patents expires or is finally determined by the United Sates Patent Office or a court of competent jurisdiction to be invalid. (c) There will be a cap of $[******] on Continuing Royalties with respect to sales of Products in [********]. No further Continuing Royalties will accrue in [********] after a total of $[********] Continuing Royalties is payable with respect to each [********]. (d) For avoidance of doubt, the Continuing Royalty will payable with respect to all sales of Products including government sales and sales into countries where the Intellectual Property has no patent protection. (e) The Continuing Royalty rates for each of the calendar years following Successful Commercialization of the Intellectual Property by Buyer are as follows: • Year [**] [***]% of Component Cost of display module • Year [**] [***]% of Component Cost of display module • Year [**] [***]% of Component Cost of display module • Year [**] [***]% of Component Cost of display module • Year [**] [***]% of Component Cost of display module • Year [**] to [********] $[***] per display module A display module is considered to be the set of components for displaying an image to one eye, so binocular eyeglasses would be considered to comprise two display modules. All Continuing Royalties on sales of products before Successful Commercialization are to be calculated at a rate of [***]% of Component Costs. (f) Continuing Royalties shall be paid by Buyer to Seller for each Payment Period no later than the Payment Date. (g) Buyer shall tender payments of the Continuing Royalties due on each Payment Date by wire transfer to such account or accounts as Seller may designate in advance. (h) Buyer shall pay the Continuing Royalties in US Dollars. Conversion of other currencies to US Dollars will be made based on conversion rates published in the Wall Street Journal on the last day of each Payment Period. (i) Buyer’s obligation to pay Continuing Royalties to Seller shall terminate upon expiration of the last Patents or upon it being deemed invalid by the US Patent Office (or the applicable patent authority in another country). (j) Interest shall accrue on the unpaid balance of any Continuing Royalties at ...